A
ANI Pharmaceuticals, Inc.
ANIP · NASDAQ · Healthcare · 1.7B
Closing price
$73.89
+2.65% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
18.9×
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
7.3×
Free cash flow yieldFCF yield
10.2%
Return on equityROE
14.5%
Operating margin
9.2%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
4.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.